Patents by Inventor Kenneth Walter Bair

Kenneth Walter Bair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted Lactams and Their Use as Anti-Cancer Agents
    Publication number: 20080275025
    Abstract: This invention relates to certain substituted lactam compounds, particularly caprolactam compounds, which are useful for the treatment of cancer.
    Type: Application
    Filed: May 7, 2008
    Publication date: November 6, 2008
    Inventors: Kenneth Walter Bair, Frederick Ray Kinder, Richard William Versace
  • DEACETYLASE INHIBITORS
    Publication number: 20080176849
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Application
    Filed: March 11, 2008
    Publication date: July 24, 2008
    Inventors: Stacy William Remiszewski, Kenneth Walter Bair, Richard William Versace, Lawrence Blas Perez, Michael Alan Green, Lidia Cristina Sambucetti, Sushil Sharma
  • Substituted lactams and their use as anti-cancer agents
    Patent number: 7378410
    Abstract: This invention relates to certain substituted lactam compounds of the formula (I), particularly caprolactam compounds, which are useful for the treatment of cancer
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: May 27, 2008
    Assignee: Novartis AG
    Inventors: Kenneth Walter Bair, Frederick Ray Kinder, Jr., Richard William Versace
  • Substituted lactams and their use as anti-cancer agents
    Publication number: 20060281731
    Abstract: This invention relates to certain substituted lactam compounds of the formula (I), particularly caprolactam compounds, which are useful for the treatment of cancer.
    Type: Application
    Filed: July 23, 2004
    Publication date: December 14, 2006
    Inventors: Kenneth Walter Bair, Frederick Kinder Jr., Richard Versace
  • Deacetylase inhibitors
    Patent number: 6833384
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Grant
    Filed: November 19, 2002
    Date of Patent: December 21, 2004
    Assignee: Novartis AG
    Inventors: Stacy William Remiszewski, Kenneth Walter Bair, Richard William Versace, Lawrence Blas Perez, Michael Alan Green, Lidia Cristina Sambucetti, Sushil Sharma
  • Inhibitors of the E2F-1/cyclin interaction for cancer therapy
    Publication number: 20040077549
    Abstract: The novel compounds of this invention have the general structural formula Ia-d: The compounds of this invention relate to 8-mer, 7-mer, 6-mer and 5-mer peptides having the following amino acid-sequences, and referred to collectively as having “Formula Ia-d”: 1 Cap-AA8-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 8-mer la Cap-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 7-mer lb Cap-AA6-AA5-AA4*-AA3-AA2-AA1* 6-mer lc Cap-AA5-AA4*-AA3-AA2-AA1* 5-mer ld
    Type: Application
    Filed: June 27, 2003
    Publication date: April 22, 2004
    Inventors: Kenneth Walter Bair, YingNan Pan Chen, Timothy Michael Ramsey, Michael Lloyd Sabio, Sushil Kumar Sharma
  • Inhibitors of the E2F-1/cyclin interaction for cancer therapy
    Publication number: 20040053849
    Abstract: The novel compounds of this invention have the general structural formula Ia-d: The compounds of this invention relate to 8-mer, 7-mer, 6-mer and 5-mer peptides having the following amino acid sequences, and referred to collectively as having “Formula Ia-d”: 1 Cap-AA8-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 8-mer Ia Cap-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 7-mer Ib Cap-AA6-AA5-AA4*-AA3-AA2-AA1* 6-mer Ic Cap-AA5-AA4*-AA3-AA2-AA1* 5-mer Id
    Type: Application
    Filed: June 25, 2003
    Publication date: March 18, 2004
    Inventors: Kenneth Walter Bair, YingNan Pan Chen, Timothy Michael Ramsey, Michael Lloyd Sabio, Sushil Kumar Sharma
  • Use of certain substituted caprolactam carbonates and ethers in treating tumors
    Patent number: 6599898
    Abstract: The present invention relates to certain substituted caprolactam carbonate and ether compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: July 29, 2003
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Richard William Versace, Kenneth Walter Bair
  • Use of certain substituted caprolactams in treating tumors
    Patent number: 6555533
    Abstract: The present invention relates to certain substituted caprolactam compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: April 29, 2003
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin
  • Deacetylase inhibitors
    Patent number: 6552065
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: April 22, 2003
    Assignee: Novartis AG
    Inventors: Stacy William Remiszewski, Kenneth Walter Bair, Richard William Versace, Lawrence Blas Perez, Michael Alan Green, Lidia Cristina Sambucetti, Sushil Sharma
  • Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors
    Publication number: 20030055041
    Abstract: The present invention relates to certain substituted caprolactam carbonate and ether compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Application
    Filed: May 17, 2002
    Publication date: March 20, 2003
    Inventors: Frederick Ray Kinder, Richard William Versace, Kenneth Walter Bair
  • Inhibitors of the E2F-1/cyclin interaction for cancer therapy
    Publication number: 20020142966
    Abstract: The novel compounds of this invention have the general structural formula Ia-d: The compounds of this invention relate to 8-mer, 7-mer, 6-mer and 5-mer peptides having the following amino acid sequences, and referred to collectively as having “Formula Ia-d”: 1 Cap-AA8-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 8-mer Ia Cap-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 7-mer Ib Cap-AA6-AA5-AA4*-AA3-AA2-AA1* 6-mer Ic Cap-AA5-AA4*-AA3-AA2-AA1* 5-mer Id
    Type: Application
    Filed: December 19, 2001
    Publication date: October 3, 2002
    Inventors: Kenneth Walter Bair, YingNan Pan Chen, Timothy Michael Ramsey, Michael Lloyd Sabio, Sushil Kumar Sharma
  • Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors
    Patent number: 6413954
    Abstract: The present invention relates to certain substituted caprolactam carbonate and ether compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: July 2, 2002
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Richard William Versace, Kenneth Walter Bair
  • Use of certain substituted caprolactams in treating tumors
    Publication number: 20010044433
    Abstract: The present invention relates to certain substituted caprolactam compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Application
    Filed: March 12, 2001
    Publication date: November 22, 2001
    Inventors: Frederick Ray Kinder, Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin
  • Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
    Patent number: 6239127
    Abstract: The present invention relates to certain substituted caprolactam compounds of formula (I), where R1 is (C1-6)alkyl or (C3-6)cycloalkyl; R2 hydrogen or (C1-6)alkyl; X is (C1-12)alkynylene; (C2-12)alkynylene; m is 0 or 1; and R3 is (C3-8)cycloalkyl; or an aromatic ring system selected from (II, III, IV and V), where R4 is hydrogen, chloro, or methoxy; R5 is hydrogen, chloro, (C1-18)alkyl or (C1-18)alkoxy, and Z is oxygen, sulfur, N—H, or N—CH3; or a pharmaceutically acceptable acid addition salt thereof, where possible, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: May 29, 2001
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin